Patrick Y. Yang - 08 Mar 2024 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role: Director
Signature: /s/ Julie Shah, Attorney-in-Fact for Patrick Y. Yang
Issuer symbol: SANA
Transactions as of: 08 Mar 2024
Transactions value $: -$236,300
Form type: 4
Filing time: 11 Mar 2024, 16:57:02 UTC
Previous filing: 09 Jun 2023
Next filing: 07 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SANA	Common Stock	Sale	-$236,300	-25,000	-14.35%	$9.45	149,250	08 Mar 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.44 to $9.49, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.44 to $9.49, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.